Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Recruiting · NCT05986864 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) | Neovascular Age-related Macular Degeneration | Recruiting | Phase 1 / Phase 2 | 2026-08-28 | NCT05986864 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Skyline Therapeutics (US) Inc. | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Hospital | Beijing | China | 16 |
| Eye Hospital, WMU (Zhejiang Eye Hospital) | Wenzhou | China | 2 |
| Ophthalmic Consultants of Boston | Boston | United States | 23 |
| Peking Union Medical College Hospital | Beijing | China | 112 |
| Retina Consultants of Texas | Katy | United States | 14 |
| Retina Vitreous Associates of Florida - Saint Petersburg | St. Petersburg | United States | 6 |
| The Second Hospital of Anhui Medical University | Hefei | China | 21 |
| Wagner Kapoor Research institute | Norfolk | United States | 2 |
| Zhejiang Provincial People's Hospital | Hangzhou | China | 34 |